Zoetis Inc. (ZTS) shares reached a 52-week low of $70.97, down 1.25% from the previous close. The stock has declined 50.51% over the past year, with a 52-week high of $148.79. The company's market capitalization stands at $29.6 billion, and its P/E ratio is 11.8.
Zoetis reported adjusted diluted EPS of $1.87 for the second quarter of 2026, surpassing the $1.86 forecast. However, revenue of $2.5 billion fell short of the $2.51 billion estimate. The company revised its full-year outlook downward due to weaker demand in companion animals and increased competition.
Analysts have reacted to the earnings report with mixed ratings and revised price targets. William Blair downgraded Zoetis from Outperform to Market Perform, citing risk-to-reward considerations. Stifel maintained a Hold rating but reduced its price target to $80 from $85, citing weaknesses in key revenue-contributing franchises. TD Cowen retained a Buy rating but lowered its price target to $94 from $104, citing declining clinic visits and competitive pressures. InvestingPro notes that 13 analysts have revised their earnings downwards for the upcoming period.
Despite the stock's decline, Zoetis maintains a 13-year dividend growth streak. The company's full-year outlook revision reflects challenges in the companion animal market and increased competition.
